The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Replicative Senescence of Activated Human Hepatic Stellate Cells Is Accompanied by A Pronounced Inflammatory But Less Fibrogenic Phenotype
Open accessAbstract
Limited proliferative capacity is a characteristic of most normal human cells and results in a growth–arrested state, called replicative senescence . Functional expression of the telomerase catalytic subunit (human telomerase reverse transcriptase; hTERT) in human activated hepatic stellate cells (HSCs) rescues them from death with immortalization and maintains an activated HSC phenotype. The aim of this study was to evaluate alterations in gene and protein expression of in vitro aged human activated HSCs and to define the pathway by which senescent–activated HSCs are eliminated in culture. Altered patterns of gene expression in senescent human HSCs were assessed using DNA microarray analysis and compared with early passage HSCs or hTERT immortalized HSCs. Senescent HSCs showed higher expression of inflammation and stress–associated genes as compared with early passage HSCs. Senescent HSCs expressed reduced levels of extracellular matrix proteins, including collagens, tenascin, and fibronectin. TUNEL staining of senescent HSCs showed approximately 21% positive cells, indicating DNA fragmentation and apoptosis. Apoptosis involved the mitochondrial pathway with decreased levels of Bcl–2 and Bcl–x L protein, release of cytochrome c, and increased caspase–3 activity. In contrast, 4% to 5% of early activated HSCs or telomerase positive HSCs were TUNEL positive. In conclusion, cultured human HSCs undergo a switch from a fibrogenic to an inflammatory phenotype, suggesting that senescent human HSCs might modulate chronic wound healing processes. Maintenance of telomere length represents an important survival factor for activated human HSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results provide a causal explanation for earlier findings showing that the presence of senescent hepatic stellate cells correlates with increased inflammation but reduced fibrosis (148).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [148]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In response to liver injury, hepatic stellate cells (HSC) began to proliferate and produce extracellular matrixes for tissue repair before undergoing cellular senescence to prevent fibrosis.38, 39”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K. N., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,913
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,125
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Flagged first, then by citations
Research works printed but not linked: 6
- Abdel-Aziz, 1990, Am J Pathol, 137, 1333
- Saile, 1997, Am J Pathol, 151, 1265
- Miyashita, 1994, Oncogene, 9, 1799
- Greenwel, 1993, Lab Invest, 69, 210
- Sheron, 1993, Hepatology, 18, 41
- Maher, 1998, Am J Physiol, 275, g847
Cited by
Sorted by citations
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El‐Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,484
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
“This is consistent with previous reports on expression of interleukins, including IL-6 and IL-8, being increased in senescent cells (Mason et al., 2004; Schnabl et al., 2003), and these reports also indicate that this is seen for different cell types and for oncogenes in addition to BRAF.”
ResultMolecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Senolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098
Apoptosis: The nexus of liver injury and fibrosis
Canbay, A. E., Friedman, S. L., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 536
Strategies for targeting senescent cells in human disease
Gasek, N. S., Kuchel, G. A., Kirkland, J. L., & Xu, M. (2021) · Nature Aging · doi:10.1038/s43587-021-00121-8 · Cited by 501
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Kong, X., Feng, D., Wang, H., Hong, F., Bertola, A., Wang, F.-S., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.25744 · Cited by 448
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 449
Self-citationAydin, M. M., & Akçalı, K. C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17330 · Cited by 397
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L. W., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 387
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
Gao, B., Radaeva, S., & Park, O. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309135 · Cited by 383
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333
Recent advancement of molecular mechanisms of liver fibrosis
Seki, E., & Brenner, D. A. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.245 · Cited by 302
Self-citationHepatic stellate cells and the reversal of fibrosis
Kisseleva, T., & Brenner, D. A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04584.x · Cited by 283
Self-citationWidjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 279
Guo, C., Pan, Q., Li, D., Sun, H., & Liu, B. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.025 · Cited by 280
Tanwar, S., Rhodes, F., Srivastava, A., Trembling, P. M., & Rosenberg, W. M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i2.109 · Cited by 261
Ramakrishna, G., Rastogi, A., Trehanpati, N., Sen, B., Khosla, R., & Sarin, S. K. (2013) · Liver Cancer · doi:10.1159/000343852 · Cited by 244
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
Wobser, H., Dorn, C., Weiß, T. S., Amann, T., Bollheimer, C., Büttner, R., Schölmerich, J., & Hellerbrand, C. (2009) · Cell Research · doi:10.1038/cr.2009.73 · Cited by 245
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Müller, M. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 243
Loo, T. M., Miyata, K., Tanaka, Y., & Takahashi, A. (2020) · Cancer Science · doi:10.1111/cas.14266 · Cited by 232
The ECM path of senescence in aging: components and modifiers
Levi, N., Papismadov, N., Solomonov, I., Sagi, I., & Krizhanovsky, V. (2020) · The FEBS Journal · doi:10.1111/febs.15282 · Cited by 219
Severino, V, Alessio, N., Farina, A., Sandomenico, A., Cipollaro, M., Peluso, G., Galderisi, U., & Chambery, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.445 · Cited by 214
Li, F., Huangyang, P., Burrows, M., Guo, K., Riscal, R., Godfrey, J. T., Lee, K. E., Lin, N., Lee, P., Blair, I. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0511-2 · Cited by 216
Immunosurveillance of senescent cells: the bright side of the senescence program
Sagiv, A., & Krizhanovsky, V. (2013) · Biogerontology · doi:10.1007/s10522-013-9473-0 · Cited by 208
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Ezhilarasan, D., Sokal, E., & Najimi, M. (2018) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/j.hbpd.2018.04.003 · Cited by 204
Akkız, H., Gieseler, R. K., & Canbay, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147873 · Cited by 191
Cellular and molecular mechanisms in liver fibrogenesis
Novo, E., Cannito, S., Paternostro, C., Bocca, C., Miglietta, A., & Parola, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.02.015 · Cited by 194
Astrocyte senescence promotes glutamate toxicity in cortical neurons
Limbad, C., Oron, T. R., Alimirah, F., Davalos, A. R., Tracy, T. E., Gan, L., Desprez, P.-Y., & Campisi, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227887 · Cited by 183
Adachi, M., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.21991 · Cited by 188
Self-citationHepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives
Zhang, M., Salas, S. S., Damba, T., Borghesan, M., Demaria, M., & Moshage, H. J. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111572 · Cited by 192
Carloni, V., Luong, T. V., & Rombouts, K. (2014) · Liver International · doi:10.1111/liv.12465 · Cited by 177
Valdes, A. M., Richards, J. B., Gardner, J. P., Swaminathan, R., Kimura, M., Xiaobin, L., Aviv, A., & Spector, T. D. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0357-5 · Cited by 164
Novo, E., Marra, F., Zamara, E., di Bonzo, L. V., Monitillo, L., Cannito, S., Petrai, I., Mazzocca, A., Bonacchi, A., Franco, R. S. M. D., et al. (2006) · Gut · doi:10.1136/gut.2005.082701 · Cited by 168
Natural killer and natural killer T cells in liver fibrosis
Gao, B., & Radaeva, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.008 · Cited by 165
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Rockey, D. C., & Friedman, S. L. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.065 · Cited by 157
Adachi, M., Osawa, Y., Uchinami, H., Kitamura, T., Accili, D., & Brenner, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.033 · Cited by 158
Self-citationFriend or foe? The elusive role of hepatic stellate cells in liver cancer
Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00821-z · Cited by 159
Inflammatory signaling and cellular senescence
Ren, J., Pan, J., Lu, Y.-P., Sun, P., & Han, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 153
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors
Dongiovanni, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12945 · Cited by 145
Biomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144
Jin, H., Lian, N., Zhang, F., Chen, L., Chen, Q., Lu, C., Bian, M., Shao, J., Wu, L., & Zheng, S. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.92 · Cited by 144
Liver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver
Holt, A. P., Shepherd, E. L., Lalor, P. F., Filer, A. D., Buckley, C. D., & Adams, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.020 · Cited by 144
Cellular senescence, ageing and disease
Burton, D. G. A. (2008) · AGE · doi:10.1007/s11357-008-9075-y · Cited by 140
Human hepatic stellate cell isolation and characterization
Shang, L., Hosseini, M., Liu, X., Kisseleva, T., & Brenner, D. A. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1404-4 · Cited by 131
Self-citationp53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions
Gorgoulis, V. G., Pratsinis, H., Zacharatos, P., Demoliou, C., Sigala, F., Asimacopoulos, P. J., Papavassiliou, A. G., & Kletsas, D. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700241 · Cited by 122
Stellate cells: A moving target in hepatic fibrogenesis†
Friedman, S. L. (2004) · Hepatology · doi:10.1002/hep.20476 · Cited by 120
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
Dai, H., Zhu, C., Huai, Q., Xu, W., Zhu, J., Zhang, X., Zhang, X., Sun, B., Xu, H., Zheng, M., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.034 · Cited by 114
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
Herrmann, J., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00060.x · Cited by 113
Kong, X., Feng, D., Mathews, S., & Gao, B. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12032 · Cited by 108
Liver organoid as a 3D in vitro model for drug validation and toxicity assessment
Brooks, A., Liang, X., Zhang, Y., Zhao, C., Roberts, M. S., Wang, H., Zhang, L., & Crawford, D. H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105608 · Cited by 111
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 104
Lade, A. G., Noon, L. A., & Friedman, S. L. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000042 · Cited by 103
Prestigiacomo, V., Weston, A. A., Messner, S., Lampart, F. L., & Suter‐Dick, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179995 · Cited by 102
The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis
Kisseleva, T., & Brenner, D. A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.021 · Cited by 95
Self-citationNovo, E., Marra, F., Zamara, E., di Bonzo, L. V., Caligiuri, A., Cannito, S., Antonaci, C., Colombatto, S., Pinzani, M., & Parola, M. (2005) · Gut · doi:10.1136/gut.2005.069633 · Cited by 93
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 95
Morgillo, F., Dallio, M., Corte, C. M. D., Gravina, A. G., Viscardi, G., Loguercio, C., Ciardiello, F., & Federico, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.002 · Cited by 99
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Defining therapeutic targets for liver fibrosis: Exploiting the biology of inflammation and repair
Iredale, J. P. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.011 · Cited by 80
Paik, Y., Lee, K. S., Lee, H. J., Yang, K. M., Lee, S. J., Lee, D. K., Han, K., Chon, C. Y., Lee, S. I., Moon, Y. M., et al. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700422 · Cited by 80
Self-citationMetabolic Reprogramming of Liver Fibrosis
Delgado, M. E., Cárdenas, B., Farran, N., & Fernández, M. (2021) · Cells · doi:10.3390/cells10123604 · Cited by 75
M2 Kupffer Cells Promote Hepatocyte Senescence
Wan, J., Benkdane, M., Alons, E., Lotersztajn, S., & Pavoine, C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.014 · Cited by 73
Sarkar, D., Lebedeva, I., Emdad, L., Kang, D., Baldwin, A., & Fisher, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1772 · Cited by 41
Cyclin D1 Activity Regulates Autophagy and Senescence in the Mammary Epithelium
Brown, N. E., Jeselsohn, R. M., Bihani, T., Hu, M. G., Foltopoulou, P. F., Kuperwasser, C., & Hinds, P. W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4139 · Cited by 77
Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
Han, X., Wu, Y., Yang, Q., & Cao, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107791 · Cited by 71
Obesity and Cancer: A Gut Microbial Connection
Ohtani, N., Yoshimoto, S., & Hara, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3501 · Cited by 71
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 74
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
Telomeres, NAFLD and Chronic Liver Disease
Donati, B., & Valenti, L. V. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030383 · Cited by 69
Wang, F., Li, Z., Chen, L., Yang, T., Liang, B., Zhang, Z., Shao, J., Xu, X., Yin, G., Wang, S., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.014 · Cited by 72
Bosselut, N., Housset, C., Marcelo, P., Rey, C., Burmester, T., Vinh, J., Vaubourdolle, M., Cadoret, A., & Baudin, B. (2010) · PROTEOMICS · doi:10.1002/pmic.200900257 · Cited by 66
Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction–Associated Steatohepatitis
Kisseleva, T., Ganguly, S., Murad, R., Wang, A., & Brenner, D. A. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.010 · Cited by 75
Self-citationZhang, F., Lu, Y., & Zheng, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.008 · Cited by 65
Tacke, F., Gäbele, E., Bataille, F., Schwabe, R. F., Hellerbrand, C., Klebl, F. H., Straub, R. H., Luedde, T., Manns, M. P., Trautwein, C., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9758-8 · Cited by 64
Self-citationNon-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
Li, Y., Adeniji, N., Fan, W., Kunimoto, K., & Torok, N. J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0318 · Cited by 65
The Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
Self-citationFormation of vitamin A lipid droplets in pancreatic stellate cells requires albumin
Kim, N., Yoo, W., Lee, J., Kim, H., Lee, H. S., Kim, Y.-S., Kim, D.-U., & Oh, J. (2009) · Gut · doi:10.1136/gut.2008.170233 · Cited by 60
Luo, X., Jiang, X., Li, J., Bai, Y., Li, Z., Wei, P., Sun, S., Liang, Y., Han, S., Li, X., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1670-6 · Cited by 60
Nrf2 protects stellate cells from Smad-dependent cell activation
Prestigiacomo, V., & Suter‐Dick, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201044 · Cited by 57
Activated Hepatic Stellate Cells Mediate the Differentiation of Macrophages
Chang, J., Hisamatsu, T., Shimamura, K., Yoneno, K., Adachi, M., Naruse, H., Igarashi, T., Higuchi, H., Matsuoka, K., Kitazume, M. T., et al. (2013) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01111.x · Cited by 56
Hongo, A., Okumura, N., Nakahara, M., Kay, E. P., & Koizumi, N. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-21170 · Cited by 53
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Desai, N., Sahel, D. K., Sawant, B. K. S., Postwala, H. I., Shah, Y. B., Chavda, V. P., Fernandes, C., Khatri, D. K., & Vora, L. K. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400370 · Cited by 57
Reversal of Fibrosis: No Longer a Pipe Dream?
Fallowfield, J. A., Kendall, T. J., & Iredale, J. P. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.022 · Cited by 53
Chronic lung inflammation in aging mice
Aoshiba, K., & Nagai, A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.075 · Cited by 52
Sato, R., Maesawa, C., Fujisawa, K., Wada, K., Oikawa, K., Takikawa, Y., Suzuki, K., Oikawa, H., Ishikawa, K., & Masuda, T. (2004) · Gut · doi:10.1136/gut.2003.027516 · Cited by 52
Liu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 50
Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis
Nie, Q., Duan, G.-R., Luo, X.-D., Xie, Y.-M., Luo, H., Zhou, Y., & Pan, B.-R. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i1.86 · Cited by 50
Tacke, F., Trautwein, C., Yagmur, E., Hellerbrand, C., Wiest, R., Brenner, D. A., & Schnabl, B. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04621.x · Cited by 48
Self-citationTranscriptional regulation of stellate cell activation
Friedman, S. L. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04585.x · Cited by 47
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease
Schwabe, R. F., Tacke, F., Sugimoto, A., & Friedman, S. L. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101421 · Cited by 52
Liver Fibrosis Reversion After Suppression of Hepatitis B Virus
Rockey, D. C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.003 · Cited by 45
Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
Mikirova, N. A., Jackson, J. A., Hunninghake, R., Kenyon, J., Chan, K. W. H., Swindlehurst, C. A., Minev, B., Patel, A. N., Murphy, M. P., Smith, L., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-106 · Cited by 43
Metadata
- Authors
- Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Emory University (US)
- Corresponding author
- Brenner, David
- Venue
- Hepatology
- Published
- 2003-03
- Volume
- 37
- Issue
- 3
- Pages
- 653-664
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2020573317
- Cited by
- 224
- References
- 53
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 13 · 2023: 11 · 2022: 13 · 2021: 12 · 2020: 14 · 2019: 8 · 2018: 10 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 6 · 2013: 12 · 2012: 12
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK-34987, AA-11605)
- National Institute on Alcohol Abuse and Alcoholism (AA 11605)
- National Institute of General Medical Sciences (GM41804, R01GM041804)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 34987, P30DK034987)
- Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- replicative senescence, hepatic stellate cells, telomerase reverse transcriptase, hTERT, apoptosis, mitochondrial apoptosis, Bcl-2, Bcl-xL, caspase-3, cytochrome c release, extracellular matrix proteins, inflammation, liver fibrosis, telomere length, gene expression profiling, chronic wound healing
- MeSH terms
- beta-Galactosidase, Cell Cycle, Cell Division, Cell Survival, Cytoskeletal Proteins, DNA-Binding Proteins, Hepatitis, Humans, Liver, Phenotype, RNA, Messenger, Gene Expression, Cytokines, Cellular Senescence, Reactive Oxygen Species, Intercellular Adhesion Molecule-1, Chemokines, Vascular Cell Adhesion Molecule-1, Telomerase, Caspases, In Situ Nick-End Labeling, Oligonucleotide Array Sequence Analysis, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
